Back to News
Market Impact: 0.25
Celularity Faces Nasdaq Compliance Issue Over Delayed 10-Q Filings
Source: Nasdaq
Legal & LitigationCompany FundamentalsRegulation & Legislation
Celularity Inc. (CELU) received a Nasdaq notification on Aug. 21, 2026 for non-compliance with Listing Rule 5250(c)(1) stemming from delayed 10-Q filings. The update flags ongoing disclosure/timeliness issues that can pressure investor confidence even though no financial results were reported.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
CELU-0.55
More News
- Nvidia GPUs are everywhere. Here are the ways companies are accessing them
- Bank of America is bullish on these top stocks ahead of earnings
- As companies pour billions into Earth-based AI infrastructure, Google is taking the data center race off-planet
- How U.S. know-how is fracking Australia into a gas boom, from Texas oilmen to Trump’s energy secretary
- The world needs Ukraine’s grain. Its farmers are running out of reasons to plant
- Verizon stock heads for worst day since 2002 as SpaceX U.S. network plans whack telcos
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How to Search Earnings Call Transcripts With AI
- What a Concept From Nature Tells Us About How C-Suite Executives Actually Think About AI